NCT07279532 2025-12-12Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging SystemSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Not yet recruiting35 enrolled